Focus on a special tool for postprandial glucose control: Ultra rapid lispro
Authors:
- 1 June 2023
- journal article
- editorial
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 68 (19) , 2421-2423
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump StudyDiabetes Technology & Therapeutics, 2020
- Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2DDiabetes Care, 2020
- Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D studyDiabetes, Obesity and Metabolism, 2020
- Glycaemic variability in diabetes: clinical and therapeutic implicationsThe Lancet Diabetes & Endocrinology, 2019
- Blood glucose profiles in East Asian and Caucasian injection‐naive patients with type 2 diabetes inadequately controlled on oral medication: a pooled analysisDiabetes/Metabolism Research and Reviews, 2018
- EADSG Guidelines: Insulin Therapy in DiabetesDiabetes Therapy, 2018
- Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized MedicationDiabetes, 2017
- Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012New England Journal of Medicine, 2017
- Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United StatesAnnals of the New York Academy of Sciences, 2013
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998